Las garrapatas son muy resistentes al tiempo inclemente
LUNES, 5 de junio de 2023 (HealthDay News) — Las garrapatas tienen una resiliencia extrema, incluso cuando las temperaturas varían mucho, según unos científicos que trabajan para comprender mejor la propagación de la enfermedad de Lyme. En su nuevo e…
Learn MoreFDA Warns Against Using Bogus Treatments for Molluscum
MONDAY, June 5, 2023 (HealthDay News) — Patients may be tempted to treat little skin bumps on their own, but that can delay proper diagnosis and treatment that may work better, federal regulators caution.
Products marketed as treatments for molluscum…
FDA Warns Against Using Bogus Treatments for Skin Condition Molluscum
MONDAY, June 5, 2023 (HealthDay News) — It’s tempting to treat little skin bumps on your own, but that delays proper diagnosis and treatment that may work better, federal regulators cautioned.Among the many types of skin conditions a person can contr…
Learn MoreTicks Can Take a Licking From Really Tough Weather
MONDAY, June 5, 2023 (HealthDay News) — Ticks are extremely resilient even when temperatures vary wildly, according to scientists who are working to better understand the spread of Lyme disease.In their new study, black-legged ticks, notorious for ca…
Learn MoreNovel Dialysis Device Safe, Effective for Acute-on-Chronic Liver Failure
FRIDAY, June 2, 2023 (HealthDay News) — The DIALIVE novel liver dialysis device seems safe and has a positive impact for patients with acute-on-chronic liver failure (ACLF), according to a study published online May 31 in the Journal of Hepatology.Ba…
Learn MoreNovel Dialysis Device Safe, Effective for Acute-on-Chronic Liver Failure
FRIDAY, June 2, 2023 (HealthDay News) — The DIALIVE novel liver dialysis device seems safe and has a positive impact for patients with acute-on-chronic liver failure (ACLF), according to a study published online May 31 in the Journal of Hepatology.Ba…
Learn MoreIntranasal Ketamine Seems Effective for Refractory Chronic Migraine
FRIDAY, June 2, 2023 (HealthDay News) — Intranasal ketamine seems effective for refractory chronic migraine, with about half of patients reporting it as very effective, according to a study published online May 30 in Regional Anesthesia & Pain Medici…
Learn MoreIntranasal Ketamine Seems Effective for Refractory Chronic Migraine
FRIDAY, June 2, 2023 (HealthDay News) — Intranasal ketamine seems effective for refractory chronic migraine, with about half of patients reporting it as very effective, according to a study published online May 30 in Regional Anesthesia & Pain Medici…
Learn MoreIs a Liver Dialysis Device on the Horizon?
FRIDAY, June 2, 2023 (HealthDay News) — A new liver dialysis device might soon be able to save patients on the edge of death from liver failure, early clinical trial results show.The DIALIVE device safely improved organ function and alleviated sympto…
Learn MoreNo Need to Avoid Exercise After Prolapse Surgery, Study Finds
FRIDAY, June 2, 2023 (HealthDay News) — It may not be necessary for people who have prolapse surgery for pelvic floor disorders to wait to get started exercising again.A new study challenges standard restrictions, finding that those who resume exerci…
Learn More